7 November 2011
In the past decade the amount of time and resources to bring a new biotech crop to market has peaked at over 13 years and US$136 million according to a new survey released by CropLife International and Phillips McDougall, a global business research organization. The first ever survey of the six major biotech crop developers measured the how time and cost have changed of this process in the last decade and examined the long and intricate path a new biotech crop must navigate in order to move from the laboratory to the marketplace and finally to a farmer’s field.
Phillips McDougall found that the longest and most costly phase of the product development timeline is the regulatory and authorization phase. The survey also found that the time for a new product to receive regulatory authorization has increased 47% since 2002. This increase in time and cost runs the risk of slowing the innovation cycle to a point where farmers cannot get the technology they need in order to improve productivity in a sustainable way, especially when the world demand for food is on the rise.
“Last week, the world population reached 7 billion, and is expected to reach 9 billion by 2050. This further increases the pressure on farmers to meet world food demands and help reduce food price volatility,” said Matthew Cossey, Chief Executive Officer, CropLife Australia. “This survey illustrates the potential risk to innovation and the availability of new seed technologies that can help increase much needed productivity. What’s more, the increasing regulatory costs and burdens are potentially having a negative impact on important research being conducted by public institutions and small-to-medium-enterprises.
“The plant science industry encourages governments to revisit their regulatory requirements and determine if there are ways to maintain product safety and efficacy, while ensuring farmers have timely availability to new products and agricultural tools.”
The survey reports that prior to 2002, companies spent about four years working with governments to ensure products met regulatory requirements. Today, despite 15 years and over three billion hectares of biotech crops being grown without a single incident, companies now devote over five and a half years to meet all environmental and safety hurdles.
With this rising regulatory challenge and increased time, companies are now investing more than ever in the process. For a crop introduced between 2008 and 2012 it will cost approximately $136 million dollars and an average of 13 years before a seed is ever planted in a farmer’s field. Innovation will be at the core of the ongoing success of Australian agriculture, and the Australian Government must ensure its public policy settings and regulatory frameworks are encouraging this innovation, specifically in the plant science industry.
“Biotech seeds have added over 64 billion dollars in value to the global farming community since introduction, with over 50% going to developing world farmers,” explained Matthew Cossey. “For innovators to continue to provide benefits to farmers through new technologies such as drought resistant crops, governments must ensure efficient regulatory regimes that both protect safety and offer a streamlined process for providing farmers with technologies that can help increase production and improve their lands and livelihoods.”
To learn more about and download the study, visit http://www.croplife.org/PhillipsMcDougallStudy